Table 1.
Patient baseline demographics
Demographics mean (SD) or n (%) | Non-operative controls n = 25 | Sleeve gastrectomy n = 18 | Roux-en-Y gastric bypass n = 27 | p-value |
---|---|---|---|---|
Number of patients (n) | 25 | 18 | 27 | - |
Age at surgery (years) | 47.7 (8.7) | 47.9 (9.7) | 47 (9.9) | 0.940 |
Sex (female) | 20 (80.0%) | 17 (94.4%) | 25 (92.6%) | 0.356 |
Height (m) | 1.67 (0.07) | 1.69 (0.07) | 1.67 (0.08) | 0.725 |
Body mass index (kg/m2) | 47.1 (7.3) | 40.8 (5.7) | 42.9 (4.2) | 0.002 |
General anxiety disorder | 7 (28.0) | 10 (55.6) | 11 (40.7) | 0.194 |
Coronary artery disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.000 |
Depression | 13 (52.0) | 10 (55.6) | 15 (55.6) | 0.982 |
Type 2 diabetes | 2 (8.0) | 1 (5.6) | 3 (11.1) | 0.877 |
Dyslipidemia | 8 (32.0) | 8 (44.4) | 6 (22.2) | 0.301 |
Gastroesophageal reflux | 8 (32.0) | 8 (44.4) | 13 (48.2) | 0.505 |
Hypertension | 8 (32.0) | 6 (33.3) | 10 (37.0) | 0.949 |
Hypothyroidism | 4 (16.0) | 5 (27.8) | 6 (22.2) | 0.661 |
Fatty liver disease | 4 (16.0) | 5 (27.8) | 5 (18.5) | 0.649 |
Osteoarthritis | 12 (48.0) | 9 (50.0) | 9 (33.3) | 0.444 |
Polycystic ovarian syndrome | 1 (4.0) | 3 (16.7) | 2 (7.4) | 0.428 |
Asthma | 4 (16.0) | 2 (11.1) | 5 (18.5) | 0.916 |
Obstructive sleep apnea | 11 (44.0) | 10 (55.6) | 15 (55.6) | 0.718 |
Ex-smoker | 8 (32.0) | 1 (5.6) | 6 (22.2) | 0.120 |
EOSS 0 1 2 3 |
0 (0.0) 2 (8.0) 21 (84.0) 2 (8.0) |
0 (0.0) 1 (5.6) 16 (88.9) 1 (5.6) |
3 (11.1) 3 (11.1) 20 (74.1) 1 (3.7) |
0.625 |
EOSS, Edmonton obesity staging system.